DRUG ENFORCEMENT ADMINISTRATION ISSUES RULE: FOURTH TEMPORARY EXTENSION OF COVID-19 TELEMEDICINE FLEXIBILITIES FOR PRESCRIPTION OF CONTROLLED MEDICATIONS

WASHINGTON, Dec. 31 -- Drug Enforcement Administration has issued a rule called: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.

The rule was published in the Federal Register on Dec. 31 by Gregory Aul, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

For more information, contact Heather Achbach, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, VA 221...